4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-004198
Chief Executive Officer sold 21,172 shares at $8.22 ($173,996)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2025-01-08 | Sale | −21,172 | $8.22 | $173,996 | 273,616 | D: show line 1 in the form |
| Open-market sales · 21,172 sh · avg $8.22 · $173,996 | |||||||
Loading xslF345X05/ownership.xml…